Navigation Links
Interleukin Genetics to Host Third Quarter 2007 Financial Results Conference Call November 7
Date:11/2/2007

Conference Call Scheduled for 4:30 PM EST - November 7, 2007

WALTHAM, Mass., Nov. 2 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI) today announced that it will release its third quarter financial results on Wednesday, November 7 after the market closes. The Company's management will host the conference call at 4:30 PM EST to review Interleukin's 2007 third quarter financial results and provide management updates.

Conference Call Details

To access the live call on November 7, 2007 at 4:30 PM EST, dial (800) 366-3964 (domestic) or (303) 205-0055 (international). The call will also be available live via webcast at http://www.ilgenetics.com.

Replay access of the teleconference will be available for two weeks following the call by calling (800) 405-2236 (domestic) or (303) 590-3000 (international). The passcode for the replay is 11101550. The webcast will be archived following the call at http://www.ilgenetics.com.

About Interleukin

Interleukin Genetics, Inc. (Amex: ILI - News) is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. Interleukin currently offers an array of Nutraceuticals and OTCeuticals, including Ginkoba(R), Ginsana(R) and Venastat(R) which are sold at the nation's largest food, drug and mass retailers, and has commercialized genetic tests for periodo
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Diptheria Toxin And Interleukin2 Help Killing Melanoma Tumour Cells
2. Genetics and cholesterol levels
3. Genetics helps in attacking cancer
4. Alcoholism Influenced By Both Genetics & Family Environment
5. Genetics linked to leukemia treatment success rate in children
6. Genetics Has A Major Role To Play In Body Shape.
7. Revolution in Genetics to Open Avenues for Treating Cancer
8. AIDS research and genetics...
9. Faster way of producing Bird flu vaccine using Reverse Genetics
10. Genetics of Ageing with Preserved Mental Capacity.
11. Generation Scotland To Examine Relation Between Lifestyle, Genetics and Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...e American Society for Gastrointestinal Endoscopy ...opy in the bariatric surgery patient. The rising p...success in surgical interventions led to a marked ...rformed in the U.S., from 13,365 in 1998 to 102,79... preoperative patient and the postoperative patien...
(Date:7/25/2008)...ent of Defense and Federal Agencies in, the execu... Phoenix is a, four-day, multi-agency collaborat...ate and local agencies with large and complex inci...a vital, ad-hoc, secure mobile communications in... NORFOLK, Va., July 25 /PRNewswire/ -- Dataline L...
(Date:7/25/2008)...The Elekta Family of Companies will,showcase their...2008,American Association of Physicists in Medicin...nt forces of Elekta, IMPAC and CMS are delivering,...ry solutions that,streamline the treatment process...ll as enhance clinician efficiency., "Our recent ...
(Date:7/25/2008)... delivers immediate cost savings for http://www.l... language interpreters] to firms switching langua... Washington, D.C. (Vocus)....com/index.html [(Language Learning Enterprises, ...slation, and language instruction services to thou...
Breaking Medicine News(10 mins):Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3
...long with calcium, protein may also an important r...m is essential for building and maintaining health...and women who were taking calcium citrate malate a...t bone mineral density increased most in people wh...
... key mechanism disease-fighting cells which are us...oc with the digestive system and which has been im...alysis of the defense tactics of the immune system...pinpoint a molecule that engineers search-and-dest...
... anti-viral compounds has proved much more potent ... a promising new direction in AIDS research. These... tissue. Both publications are peer-reviewed journ...e world's largest scientific society.// The compo...
...ndheld echocardiography machines will be used to q...rmalities. The smaller machines can detect heart a...used by physicians with just minimal training, say...ults of his new study at Duke University.// For ye...
Other Medicine News:Health News:Calcium and Protein Equals Strong Bones 2Health News:Molecule aids fight E. Coli Infections 2Health News:Molecule aids fight E. Coli Infections 3Health News:Research on HIV takes new direction 2Health News:Handheld ECG: stethoscope of the future 2
(Date:7/24/2008)... SOPHIA ANTIPOLIS, France, July 24 /PRNewswir...oday announced the top-line results from the 52-we...following the completion of,the 301 phase 3 study ...d,safety findings and efficacy was maintained for ... the patients, global assessment scale. In,additio...
(Date:7/23/2008)... WASHINGTON, July 23 /PRNewswire-USNewswire/ ...nt of Justice:, Chairman Conyers, Ranking Member ... the opportunity to testify today., Since I appea... have,become even better acquainted with the talen...artment and with the work they do, and I have come...
(Date:7/23/2008)... SEATTLE, July 23 /- D...ed that it expects the Independent Data,Monitoring...terim analysis,of overall survival relating to the...ate AdenoCarcinoma Treatment, also known as D9902B...OVENGE is the Company,s investigational,active cel...
(Date:7/22/2008)... MINNEAPOLIS, July 22 /- Nonin M...oring solutions for more than 20 years, has entere... technology to measure,regional oxygen saturation....gy is the continuous monitoring of the regional bl..., Early testing data and outcomes from an ongoing...
Breaking Medicine Technology:NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Aerosol launches immune response in lungs to wipe out lethal infections 7405 1Aerosol launches immune response in lungs to wipe out lethal infections 7405 2Aerosol launches immune response in lungs to wipe out lethal infections 7405 3Sunesis Pharmaceuticals Appoints Lesley A Stolz Ph D Vice President Corporate and Business Development 2037 1Sunesis Pharmaceuticals Appoints Lesley A Stolz Ph D Vice President Corporate and Business Development 2037 2Sunesis Pharmaceuticals Appoints Lesley A Stolz Ph D Vice President Corporate and Business Development 2037 3Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds 957 1Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds 957 2Humans not the major target of Shiga toxin 1423 1Humans not the major target of Shiga toxin 1423 2
...ary results from,the immunotherapeutic cancer stud... very good safety profile for SBG. Furthermore,en...n observed,among several patients that have been t... antibody against neuroblastoma. , In line with th...the 1st quarter 2007, all 24 patients have now bee...
... Reata,Pharmaceuticals, Inc. today announced the p...lead anti-cancer agent, the,Synthetic Triterpenoid...n toxicities caused by traditional cancer treatmen...of the Multinational,Association of Supportive Car...ata scientists and collaborators presented data sh...
Other Medicine Technology:Biotec Pharmacon Announces Preliminary Results from the,Sloan-Kettering Clinical Study 2Biotec Pharmacon Announces Preliminary Results from the,Sloan-Kettering Clinical Study 3RTA 402 Shown to Protect Animals Against Toxicities of Standard,Cancer Treatments 2RTA 402 Shown to Protect Animals Against Toxicities of Standard,Cancer Treatments 3
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: